ADAPTIMMUNE THERAPEUTICS-ADR (ADAP) Stock Balance Sheet
NASDAQ:ADAP - Nasdaq - US00653A1079 - ADR - Currency: USD
| MRQ (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 41.05M | 91.14M | 143.99M | 108.00M | 149.90M | |||
| Marketable Securities | 18.51M | 60.47M | 2.95M | 96.60M | 219.60M | |||
| Receivables | 20.85M | 15.98M | 46.92M | 38.10M | 34.00M | |||
| Inventories | 11.76M | 7.32M | N/A | N/A | N/A | |||
| Other Current Assets | 10.82M | 13.26M | 13.70M | 12.70M | 11.80M | |||
| Total Current Assets | 103.00M | 188.17M | 207.55M | 255.40M | 415.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 48.94M | 51.22M | 71.71M | 71.50M | 51.40M | |||
| Intangibles | 3.81M | 3.88M | 330.00K | 400.00K | 1.00M | |||
| Other Non-Current Assets | 2.33M | 2.70M | 3.03M | 1.60M | 1.70M | |||
| Total Non-Current Assets | 55.07M | 57.79M | 75.06M | 73.50M | 54.00M | |||
| TOTAL ASSETS | 158.07M | 245.96M | 282.62M | 328.90M | 469.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 26.84M | 35.61M | 35.64M | 31.80M | 31.90M | |||
| Accounts Payable | 5.70M | 8.69M | 8.13M | 4.80M | 8.10M | |||
| Other Current Liabilities | 18.53M | 20.23M | 29.02M | 28.00M | 22.50M | |||
| Total Current Liabilities | 51.07M | 64.53M | 72.79M | 64.50M | 62.50M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 25.41M | 50.24M | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 119.02M | 119.35M | 170.31M | 182.50M | 201.00M | |||
| Total Non-Current Liabilities | 144.43M | 169.59M | 170.31M | 182.50M | 201.10M | |||
| TOTAL LIABILITIES | 195.50M | 234.11M | 243.10M | 247.00M | 263.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.14B | -1.09B | -1.02B | -909.30M | -743.80M | |||
| Additional Paid In Capital | 1.11B | 1.11B | 1.06B | 990.70M | 959.60M | |||
| Common Shares | 2.10M | 2.08M | 1.86M | 1.40M | 1.30M | |||
| Other Shareholders' Equity | -4.41M | -1.92M | -3.75M | 100.00K | -10.80M | |||
| Shares Outstanding | 265.90M | 263.93M | 234.26M | 169.65M | 161.13M | |||
| Tangible Book Value per Share | -0.03 | 0.01 | 0.03 | 0.08 | 0.22 | |||
| Total Shareholders' Equity | -37.43M | 11.85M | 39.51M | 81.90M | 206.00M | |||
| TOTAL LIABILITIES AND EQUITY | 158.07M | 245.96M | 282.62M | 328.90M | 469.50M | |||
| Statistics | ||||||||
| Debt/Equity | -0.68 | 4.24 | N/A | N/A | N/A | |||
| Current Ratio | 2.02 | 2.92 | 2.85 | 3.96 | 6.65 | |||
| Return On Assets (ROA) | -44.22% | -28.79% | -40.29% | -50.31% | -33.67% | |||
| Return On Equity (ROE) | N/A | -597.64% | -288.19% | -202.03% | -76.74% | |||
All data in USD , ROIC based on taxRate of 0.21